PHARVARIS N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.71 USD | -1.76% |
|
+5.54% | -22.60% |
| 05-09 | Wedbush Adjusts Pharvaris' Price Target to $31 From $35, Maintains Outperform Rating | MT |
| 05-08 | Pharvaris N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PHARVARIS N.V. | Other Biotechnology & Medical Research | -1.76% | +5.54% | -22.60% | +155.41% | - | 1.19B |  | |  |
- Stock Market
- Equities
- PHVS Stock
- Charts Pharvaris N.V.
- Relative Strength Chart
